Munich (DE) Local Division
325 cases · page 1 of 11
Showing 1–29Network System Technologies LLC v.Qualcomm Incorporated
In this complex international patent dispute, Network System Technologies LLC brought an infringement action against Qualcomm Incorporated concerning European Patent EP 1 552 399, which relates to integrated circuits and transaction methods. The court ultimately dismissed the infringement claim because the Claimant failed to conclusively substantiate its allegations during the oral hearing. This decision highlights the stringent burden of proof required in UPC proceedings, emphasizing that mere dispute is insufficient when a party bears the burden of proving infringement.
BFexaQC AG v.NVIDIA Corporation and NVIDIA GmbH
In this UPC decision, the court dismissed the infringement claim against NVIDIA regarding EP 3 743 812. The patent relates to dynamic resource allocation in heterogeneous computing systems. While the main infringement suit failed, the defendant's counterclaim for revocation was not addressed because the condition precedent (the failure of the infringement action) was met. This case reinforces key procedural principles regarding claim construction and contingent counterclaims within the UPC framework.
Network System Technologies LLC v.Qualcomm Incorporated a.o.
In a significant ruling concerning network technology patents, the Local Division Munich dismissed the infringement claim brought by Network System Technologies LLC against Qualcomm Incorporated. The court found that the Claimant failed to meet its burden of proof regarding patent infringement during the oral hearing. This decision highlights the stringent evidentiary requirements placed on claimants in UPC proceedings, emphasizing that mere dispute is insufficient without conclusive factual substantiation.
Network System Technologies LLC v.Qualcomm Incorporated a.o.
In this complex international patent dispute involving Qualcomm and Network System Technologies LLC over EP 1 875 683, the UPC Local Division Munich dismissed both the infringement claim and the counterclaim for revocation. The court ruled that the Claimant failed to conclusively substantiate its allegations of infringement during the oral hearing. This decision highlights the high burden of proof required in UPC proceedings, emphasizing that mere dispute is sufficient when a claimant fails to present conclusive evidence.
BFexaQC AG v.NVIDIA Corporation
In this complex UPC case involving BFexaQC AG against NVIDIA Corporation, the court addressed both an infringement claim and a counterclaim for patent revocation. The court ultimately dismissed the infringement lawsuit concerning EP 3 743 812, which covers dynamic resource allocation in heterogeneous computing systems. Beyond the merits, the decision provided important procedural guidance regarding the non-binding nature of applicant statements during the grant phase and the conditions under which a conditional counterclaim for revocation can be handled.
Network System Technologies LLC v.Qualcomm Incorporated a.o.
In a significant decision, the UPC Local Division Munich revoked European Patent EP 1 552 669 in France and Germany. The revocation followed the dismissal of the infringement action brought by Network System Technologies LLC against Qualcomm subsidiaries. The court ruled that the Claimant failed to conclusively prove its case, allowing the Defendants' counterclaim for revocation to succeed. This decision underscores the high burden of proof required in UPC infringement proceedings.
Network System Technologies LLC v.Qualcomm Incorporated a.o.
In a complex international patent dispute involving Qualcomm and Network System Technologies LLC, the UPC Local Division Munich dismissed both the infringement action and the counterclaim for revocation concerning EP 1 875 683. The court ruled that the Claimant failed to conclusively substantiate its claims during the oral hearing, despite arguments regarding evidence production under Rule 190 RoP. This decision highlights the high burden of proof required in UPC proceedings, particularly when asserting complex technical infringement.
Network System Technologies LLC v.Qualcomm Incorporated
In this significant UPC decision, Network System Technologies LLC brought an infringement suit against Qualcomm regarding EP 1 552 669. However, the Defendants successfully mounted a counterclaim for revocation. The Local Division Munich ultimately revoked the patent in France and Germany, dismissing the infringement action entirely. This case underscores the high burden of proof required by claimants to conclusively demonstrate patent infringement before the UPC.
Quinn Emanuel Urquhart & Sullivan, LLP v.Huawei Technologies Co. Ltd.
This UPC decision addresses a procedural motion filed by the respondent (Huawei) seeking to suspend an earlier order concerning document access granted by the rapporteur. The court ruled in favor of the respondent, utilizing Rule 335 VerfO to prevent the immediate fulfillment of the access request from undermining the subsequent Panel Review. This highlights the UPC's commitment to ensuring that procedural steps do not prematurely conclude a case before the full judicial review process is complete.
Bobst Manchester Limited v.Nordmeccanica S.p.A.
This UPC CFI decision addressed a procedural application concerning the language of proceedings in an infringement case involving Nordmeccanica S.p.A. and Bobst Manchester Limited regarding EP3067437. The court ruled in favor of the defendant, granting the request to change the language from German to English. The ruling emphasized that when assessing fairness for a language change, the position of the defendant—who faces strict deadlines and must prepare its defense—is given decisive weight if interests are balanced.
Nagravision Sàrl v.Pinterest Germany GmbH, Pinterest Europe Ltd, Pinterest Inc.
This UPC decision addresses a procedural application concerning the language of proceedings in an infringement case involving Pinterest and Nagravision. The Court granted the request to change the language from German to English, aligning it with the language of the patent grant and the common working language of the multinational Defendants. This ruling emphasizes that operational efficiency and internal coordination needs of large corporate defendants can override the local language preference of a claimant in UPC proceedings.
Heraeus Electronics GmbH & Co. KG v.Vibrantz GmbH
This UPC Local Division ruling addresses a procedural challenge concerning cost determination deadlines in complex patent litigation. The court affirmed that parties can seek reinstatement (Wiedereinsetzung) under Rule 320 if they miss the deadline for filing a cost allocation request, provided there are justifiable reasons. This decision provides significant relief to litigants facing strict procedural timelines, emphasizing judicial flexibility and fairness over rigid adherence to deadlines in complex financial matters.
Emboline, Inc. v.AorticLab srl
In this UPC case, Emboline, Inc. sued AorticLab srl for infringing a patent covering an embolic protection device. The court dismissed the infringement action, finding that the defendant's product did not meet all the requirements of the patented claims. Beyond the merits, the decision provided important procedural guidance on how dependent counterclaims are limited and how costs are allocated when certain intra-procedural conditions are not met.
GXD-Bio Corporation v.Myriad International GmbH (and associated Myriad entities)
In a significant decision, the UPC Local Division Munich revoked European Patent EP 3 346 403. The patent covered methods for quantifying gene expression in breast cancer tissue using RT-PCR and normalization to endogenous reference genes. Despite GXD-Bio Corporation's infringement claims against Myriad International GmbH and its subsidiaries regarding their EndoPredict-Test, the court dismissed the infringement action following the revocation of the patent. This ruling underscores the dual nature of UPC proceedings, where a successful counterclaim for revocation can immediately extinguish an associated infringement claim.
GXD-Bio Corporation v.Myriad International GmbH (and associated Myriad entities)
In a significant decision, the UPC Local Division Munich revoked European Patent EP 3 346 403, which covered methods for quantifying gene expression in breast cancer tissue. The patent holder, GXD-Bio Corporation, had sued Myriad International GmbH and its subsidiaries for infringement, while the defendants filed a counterclaim for revocation. The court ultimately sided with the defendants on the revocation claim, invalidating the patent across all relevant territories. This case highlights the dual risk inherent in UPC proceedings: an infringement suit can be defeated by a successful revocation defense.
Sanofi SA as successor of Sanofi Mature IP v.STADAPHARM GmbH a.o.
In a significant ruling, the UPC Local Division Munich revoked European Patent 2 493 466 in its entirety. The patent, which covered a novel anti-tumoral use of cabazitaxel (marketed as JEVTANA), was found invalid across several key member states. Consequently, all associated infringement actions brought by Sanofi against generic manufacturers like STADAPHARM were dismissed. This case highlights the vulnerability of patents facing prior national challenges and underscores the UPC's role in enforcing or nullifying IP rights.
Sanofi SA as successor of Sanofi Mature IP a.o. v.Reddy Pharma SAS
In a significant pharmaceutical case, the UPC Local Division Munich revoked European Patent 2 493 466, which covered a novel anti-tumoral use of cabazitaxel. The revocation was based on prior findings of invalidity concerning the patent's scope and obviousness. Consequently, all associated infringement claims brought by Sanofi against generic manufacturers like Reddy Pharma were dismissed. This decision underscores the powerful impact of national invalidation proceedings on UPC rights.
Sanofi SA as successor of Sanofi Mature IP v.Zentiva France
In a significant pharmaceutical case, the UPC Local Division Munich revoked European Patent 2 493 466 concerning the anti-tumoral use of cabazitaxel. The revocation was based on prior invalidation proceedings in France, which demonstrated how national court decisions can directly impact patent validity within the unified system. Consequently, all associated infringement actions brought by Sanofi against generic manufacturers like Zentiva were dismissed.
ASUS Technology Licensing Inc. v.Guangdong OPPO Mobile Telecommunications Corp. Ltd
This UPC decision addressed a security for costs application filed by multiple defendants against ASUS Technology Licensing Inc., the claimant. The core issue revolved around the difficulty of enforcing cost judgments in Taiwan, where the claimant is based. Although the Defendants argued that enforcement risk was substantial due to Taiwanese legal uncertainties, the Court ultimately ordered ASUS to provide EUR 200,000 in security for costs. This ruling highlights the UPC's pragmatic approach to procedural fairness while balancing the need to protect parties against non-enforceable claims.
Sanofi SA as successor of Sanofi Mature IP a.o. v.Reddy Pharma SAS
In a significant ruling concerning pharmaceutical patents, the UPC Local Division Munich revoked European Patent 2 493 466. This patent covered a novel anti-tumoral use of cabazitaxel, which was marketed under the brand name JEVTANA by Sanofi. The revocation decision immediately dismissed all associated infringement actions brought by Sanofi against generic competitors like Reddy Pharma SAS. This case underscores the powerful effect of successful revocation proceedings within the UPC framework.
Sanofi SA as successor of Sanofi Mature IP v.Zentiva France
In a significant pharmaceutical case, the UPC Local Division Munich revoked European Patent 2 493 466 concerning the anti-tumoral use of cabazitaxel. The revocation decision effectively dismissed the concurrent infringement actions brought by Sanofi against generic manufacturers like Zentiva. This ruling underscores the power of the UPC to enforce patent validity across multiple jurisdictions, even when national court decisions regarding invalidity are involved.
Sanofi SA as successor of Sanofi Mature IP v.STADAPHARM GmbH a.o.
In a significant ruling for the pharmaceutical sector, the UPC Local Division Munich revoked European Patent 2 493 466, which covered a novel anti-tumoral use of cabazitaxel. This decision immediately dismissed the associated infringement actions brought by Sanofi against generic competitors such as Stada and Dr Reddy's. The ruling underscores the vulnerability of patents, even those related to specific medical uses, when challenged successfully on grounds of invalidity.
JingAo Solar Co., Ltd. v.Chint New Energy Technology Co., Ltd. and others (Astronergy group)
In a significant ruling, the UPC Local Division Munich found that Chint New Energy Technology Co. and its affiliates infringed the patent EP 2 787 541 concerning advanced solar cell technology. The court granted an injunction requiring the defendants to cease sales of their 'ASTRO N' series modules in key EU markets (Germany, France, Italy, Netherlands). Furthermore, the claimant was awarded interim costs, and the defendant's counterclaim for patent revocation was dismissed.
Huawei Technologies Co. Ltd. v.TP-Link Systems Inc, TP-Link Deutschland GmbH, TP-Link Entreprises France SARL, TP-LINK Enterprises Netherlands B.V, TP-Link Italia S.R.L., TP-LINK Enterprises Nordic AB, Lianzhou International Co., Ltd.
In this procedural order, the UPC Court of First Instance granted a request by TP-Link and Lianzhou to change the language of proceedings from German to English for an infringement case involving Huawei. The court balanced the interests of both parties, concluding that the Defendants' structural disadvantage in preparing their defense outweighed the Claimant's preference for the local language. This decision underscores the Court's commitment to procedural fairness and efficiency in complex international disputes.
Solvay Specialty Polymers Italy S.p.A. v.Zhejiang Fluorine Chemical New Material Co., Ltd.
This UPC decision addressed a procedural dispute regarding the composition of a confidentiality club in an ongoing infringement/revocation action involving Solvay Specialty Polymers and Zhejiang Fluorine Chemical. The Court confirmed the initial order, upholding the inclusion of non-employee experts from the claimant's economic unit. The ruling clarifies that access to confidential information is not strictly limited to direct employees, significantly broadening who can be included for effective litigation.
FAST IP, LLC v.Skechers USA Deutschland GmbH; Skechers S.a.r.l; Skechers U.S.A., Inc.; Skechers EDC SPRL; Skechers USA Italia Srl; Skechers USA France SAS (collectively, Skechers)
This procedural decision addressed an application to change the language of proceedings in a UPC infringement case from German to English. The Court sided with the defendants, Skechers, who argued that their global corporate structure and the patent's original grant language favored English. The ruling reinforces the principle that the defendant's position is decisive when assessing fairness under Article 49(5) UPCA, even if the claimant initially chose a different official language.
BFexaQC AG v.NVIDIA Corporation
In this procedural order, the UPC Local Division Munich addressed a request by NVIDIA Corporation for security for costs against BFexaQC AG and ParTec AG. Despite evidence presented regarding Claimant 2's severe liquidity issues, the Court ruled that security was necessary. The judge rapporteur set the required amount at EUR 80,500.00, emphasizing proportionality while safeguarding the Defendants' potential legal expenses.
Shangrao Xinyuan Yuedong Technology Development Co., Ltd v.LONGi Solar Technologie GmbH
This UPC decision confirms the procedural mechanism for withdrawing a patent infringement action when parties reach an out-of-court settlement. The Court permitted Shangrao Xinyuan Yuedong to withdraw its claim against LONGi Solar and related entities, provided no party had a legitimate interest in the merits of the case. Furthermore, the Claimant was granted reimbursement of 60% of the court fees paid.
AX Wireless, LLC v.Xiaomi Inc.
In a procedural order, the UPC Local Division Munich granted a request by the defendants to align and extend key deadlines in the case against AX Wireless, LLC. The court found that harmonizing the timelines for all parties, including those served internationally, would significantly improve case management efficiency. This decision underscores the Court's focus on practical, efficient procedural handling while respecting statutory requirements.
ONWARD Medical N.V. v.Niche Biomedical, Inc.
ONWARD Medical N.V. sought an injunction against Niche Biomedical, Inc., alleging infringement of its patent EP 3 421 081 B1 concerning neuromodulation systems. The Munich Local Division ultimately denied the request for provisional measures. The court emphasized that in such proceedings, attempts to modify claims to address validity doubts are typically rejected, highlighting a strict standard for injunctive relief. This decision underscores the high bar required for patentees seeking urgent interim protection under the UPC.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.